tradingkey.logo

TELA Bio Inc

TELA
View Detailed Chart
1.130USD
-0.010-0.88%
Close 12/19, 16:00ETQuotes delayed by 15 min
45.59MMarket Cap
LossP/E TTM

TELA Bio Inc

1.130
-0.010-0.88%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.88%

5 Days

-1.74%

1 Month

+6.60%

6 Months

-31.52%

Year to Date

-62.58%

1 Year

-60.35%

View Detailed Chart

TradingKey Stock Score of TELA Bio Inc

Currency: USD Updated: 2025-12-19

Key Insights

TELA Bio Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 98/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.45.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

TELA Bio Inc's Score

Industry at a Glance

Industry Ranking
98 / 208
Overall Ranking
228 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
3.450
Target Price
+205.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

TELA Bio Inc Highlights

StrengthsRisks
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 67.32% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 69.30M.
Overvalued
The company’s latest PE is -1.38, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 28.74M shares, decreasing 25.58% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.80M shares of this stock.

TELA Bio Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

TELA Bio Inc Info

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Ticker SymbolTELA
CompanyTELA Bio Inc
CEOKoblish (Antony)
Websitehttps://www.telabio.com/

FAQs

What is the current price of TELA Bio Inc (TELA)?

The current price of TELA Bio Inc (TELA) is 1.130.

What is the symbol of TELA Bio Inc?

The ticker symbol of TELA Bio Inc is TELA.

What is the 52-week high of TELA Bio Inc?

The 52-week high of TELA Bio Inc is 3.099.

What is the 52-week low of TELA Bio Inc?

The 52-week low of TELA Bio Inc is 0.865.

What is the market capitalization of TELA Bio Inc?

The market capitalization of TELA Bio Inc is 45.59M.

What is the net income of TELA Bio Inc?

The net income of TELA Bio Inc is -37.84M.

Is TELA Bio Inc (TELA) currently rated as Buy, Hold, or Sell?

According to analysts, TELA Bio Inc (TELA) has an overall rating of Buy, with a price target of 3.450.

What is the Earnings Per Share (EPS TTM) of TELA Bio Inc (TELA)?

The Earnings Per Share (EPS TTM) of TELA Bio Inc (TELA) is -0.822.
KeyAI